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ABSTRACT
We examined machine learning methods to predict death within six months using data
derived from the United States Renal Data System (USRDS). We specifically evaluated a
generalized linear model, a support vector machine, a decision tree and a random forest
evaluated within the context of K-10 fold validation using the CARET package available
within the open source architecture R program. We compared these models with the
feed forward neural network strategy that we previously reported on with this data set.
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INTRODUCTION

the USRDS in 2007 were read in the program SAS
(version 9.1), SAS Institute Inc., Cary, NC, and exported
in a CSV format. Forty-two variables were selected
to be used in the analysis based on their potential
clinical significance and their wide availability within
the USRDS as we had previously reported.9

Patients with end stage renal disease (ESRD) have
an extremely high extra renal morbidity and age
adjusted mortality compared with the general
population in the United States.1-3 A number of
factors have been identified which predict risk in
this patient population, and some of these factors
are reasonably powerful at predicting risk.4-8
We have previously reported on patient records
kept within the United States Renal Data System
(USRDS);9 a number of qualitative and quantitative
measurements are presented which can be accessed
rather easily from the National Institutes of Health.10,11
In our previous study, we found that a neural network
approach was not superior to that obtainable
with a logistic linear approach at predicting time
to death. However, since that report, advances in
machine learning have allowed for the relatively easy
application of other approaches which might help
clinicians estimate mortality risk in this population.
For that reason, the following study was performed.
Methods

All analysis was performed using the open source
program R. We used a generalized linear model as
our default.12 In addition, we examined the utility
of a support vector machine,13 decision trees with
the RPART package, neural networks (1 hidden
layer, feed forward as previously studied(9)), and
random forests.14,15 The CARET package was used for
comparison of the mature models employing 10 Kfolds and 3 repeats performed on a training set (5%
of total) chosen with different randomization seeds
to allow for reproducibility.16 Other packages within
R were used for different specific tasks (e.g., NNet for
construction of the neural network, randomForest
(RFor) for constructing random forests)17 as we
recently demonstrated with the Modification of Diet
with Renal Disease (MDRD) dataset.18

Files containing de-identified patient records from

For these studies, we focused on the categorical
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output of survival less than six months. This outcome
variable was chosen for its clinical relevance to
nephrology practice.

of ischemic heart disease and prevalence of
pulmonary disease were both higher in those dying
early (both p<0.01). Many of the data were quite

RESULTS AND
DISCUSSION
In the records that were
selected for analysis,
just over 67 thousand
subjects died within
the first six months of
starting hemodialysis
(HD) therapy whereas
the remaining 330
thousand subjects
survived longer. The
data in these two
groups are summarized
in Table 1. Those that
died early tended to
have poorer nutrition
as evidenced by a
lower serum albumin,
serum creatinine (SCr)
and body mass index
(BMI) (all p<0.01).
They also tended to
be significantly older
(68.3+/15.0 vs 61.3+/15.8, p<0.01), have a
lower prevalence of
insulin dependent
diabetes (p<0.01) and
higher EPO dosages
(p<0.01). The prevalence

TABLE 1: Comparison of Early Death (< 6 months) and Others
*Note that because number of subjects is so high in both groups, confidence intervals around point estimate for
prevalence are <<1% for all categorical values.
SCr – serum creatinine, BUN – serum urea nitrogen, ALCOH – alcohol dependency, CANCER – cancer present,
CARFAIL- cardiac failure, CVA – cerebrovascular accident, HIV – human immunodeficiency virus positive, AIDS
– acquired immunodeficiency syndrome present, DRUG – drug dependency, DYYSRYTH- cardiac arrhythmias,
EPO – erythropoietin utilization, HYPER – hypertension present, Ischemic Heart Disease present, MI – history of
myocardial infarction, NOAMBGUL- not able to ambulate, PERICARD – pericarditis, PULMON – pulmonary disease
present, PVASC – peripheral vascular disease present, SMOKE – active smoker.
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similar in the two groups although because of the
large numbers involved, statistical significance was
noted (Table 1). The high rates of HIV and AIDS
reflects the time that these data were obtained;
it is quite likely that a more recent data set would
have much lower prevalence for HIV and related
conditions.
Different machine learning approaches yielded

FIGURE 1: Receiver operator curves (ROC) achieved with
generalized linear model (GLM) - red, support vector
machine (SVM) – green, decision tree (RPart) – blue, feed
forward neural network (NNet) – orange and random
forest (RFor) – purple on testing set (95%) after training on
training set (5%) with seed 33 used for randomization.

TABLE 2: ROC areas with the different methods: GLM –
generalized linear model, SVM – support vector machine,
RPart – decision tree, NNet – feed forward neural network
with 1 hidden layer, RForest – random forest. P value
vs GLM. Each ROC determined for each method with 6
different seed values to generate selection of training and
testing sets. Training sets chosen to 5% of the total patient
records.
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somewhat different fits as assessed by ROC curves
(Figure 1, Table 2). In general, the best fits were
obtained by either the generalized linear model
(logistic regression, GLM) or the random forest
(RForest) approach with the feed-forward neural
network (NNet) just slightly behind. The SVM was
next with the decision tree (RPart) least effective.
Because the decision tree method was so weak, we
did not investigate its predictions further. In contrast
to the ROC curves which demonstrated
significant differences (Table 2), the accuracy
values obtained by the remaining four
methods were remarkably similar although
statistical inferiority to the linear model was
evidenced by both the SVM and the NNet
models. Accuracy achieved by the Rforest
was similar to that obtained by the GLM.
Sensitivity of the GLM was inferior to that
obtained by the SVM and RForest methods
whereas specificity of the NNet method was
the best. Along those lines the NNet method
had the highest positive predictive value (PPV)
where the RForest had the highest negative
predictive value (NPV). These data are all
summarized in Table 3.
The factors that were most important to the
models are shown in Table 4. It is clear that
patient age, serum creatinine and serum albumin
are important to the different models. Other
measurements made it to the top of some of the
models but not others. The different models were
remarkably consistent with the importance order
with which variables were
chosen with the different seeds
(data not shown).
As the entire data set had
a relative paucity of early
deaths, we examined how
our algorithms performed
with a balanced training set
constructed from drawing from a subpopulation
where the fraction of patients with early (< 6
month) deaths was 50:50. When we did this, all
training algorithms had dramatic increases in kappa
values (to about 0.2) as well as specificity values (to
between 0.60 and 0.65) with marked decreases in
sensitivity to be essentially matched to the specificity
value obtained with that algorithm. As accuracy
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TABLE 3: Diagnostic accuracy with different methods: Calculated from N=6 seeds.
Data shown as mean +/- SD of six determinations. PPV – positive predictive value,
NPV – negative predictive value. Positive class is “alive > 6 months.” ** p<0.01 vs
GLM.

TABLE 4: Variable importance among the different methods
Albumin- serum albumin, Incident Age – age of first ESRD treatment, SCr – serum creatinine,
BUN – serum urea nitrogen, EPO – erythropoietin use, Hypertension – presence of
hypertension.
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also decreased by about 20%, we chose to leave the
training dataset unbalanced. Manuscripts addressing
the challenge of unbalanced data sets recognize this
problem but do not offer a universal solution.19
The results we observed were not very surprising
based on our previous experience with this data set
where we saw that the neural network model did not
afford advantages over linear or actuarial strategies
at predicting time to death.9 In the current study,
the logistic linear model (as we were predicting a
categorical outcome) was, to all intents and purposes,
comparable or superior to more sophisticated
strategies at predicting early death after the initiation
of dialysis therapy. Cross talk between variables
clearly wasn’t all that important in the determination
of this important outcome; evidence strongly
supported the contention that a logistic linear model
captured most of the information present in this
large data set.
In the analysis performed, sensitivity was calculated
based on the model’s ability to predict survival.
Along with the high prevalence of survivors, the
positive predictive value was generally in excess
of 80%. This seems to be more than high enough
to merit a trial of dialytic therapy. In contrast, the
negative predictive value of the models hovered
around 50%. Frankly, this does not come close to
meeting the authors’ threshold for futility of care,
and it would seem irresponsible to withhold dialytic
therapy for such a prediction. However, it seems that
such a prediction might be of a precision sufficient to
recommend additional vigilance in monitoring. With
the ease of implementing the logistic linear model,
this seems to be a reasonable approach based on the
data used in this study which are readily available
from routine clinical records (and usually submitted
with the CMS-2728-U3 form).
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APPENDIX
rm(list=ls()) #empty memory
setwd(“C:/Users/shapiroj/Dropbox/Current Stuff/
work”) #set working directory
#load csv file and erase empty columns
library(dplyr)
dat <- read.csv(“esrd.csv”,stringsAsFactors=FALSE,na.
string=c(“”,NA,” “,”U”,”Unk”))
dim(dat)
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dat1 = dat[,!apply(is.na(dat), 2, all)] # automatically
get rid of empty cols at the end
#set up outcome variable as “yes” or “no” for
subsequent machine learning
A=NULL
mm=dim(dat1)[1]
for(i in 1:mm){
if(dat1[i,39]<6){
A[i]=”yes”
}else{
A[i]=”no”
}
}
#make all data used for fitting numeric; essential for
most machine learning algorithms
dat2=dat1[,1:38]
for(i in 1:38){
dat2[,i]=as.numeric(dat2[,i])
}
#reconstitute file z with output1 variable having
outcomes as yes or no.
z=cbind(dat2,A)
colnames(z)[39]=”output1”
#clean up some variables
z=z[,-c(1,5,38)]
#load additional libraries
library(rJava)
library(ROCR)
library(pROC)
library(rpart)
library(caret)
library(nnet)
library(C50)
library(ggplot2)
library(lattice)
library(randomForest)
library(rminer)
library(xgboost)
library(rBayesianOptimization) ## Bayesian
Optimization
#run simulations and save data
vv=c(2,33,15,19,5) #create vector with different
seeds
#loop with different seeds
for(i in 1:5){
set.seed(k)
#split into training and testing subsets based on
seed
ind = sample(2, nrow(z), replace = TRUE, prob =
c(0.5, 0.95))
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trainset = z[ind == 1,]
testset = z[ind == 2,]
#save files with output data
vvv=paste0(“esrd_10_seed_”,k,”.txt”)
www=paste0(“esrd_10_seed_”,k,”.png”)
#set up training with CARET for different machine
learning methods
control = trainControl(method = “repeatedcv”,
number = 10, repeats = 3, classProbs =
TRUE, summaryFunction = twoClassSummary)
glm.model = train(output1 ~ ., data = trainset,
method = “glm”, metric = “ROC”, trControl =
control, preProc=c(“center”,”scale”))
tunGrid_svm=expand.grid(sigma=c(0.015), C=c(1))
#sigma and C fit optimized
separately based on ROC on training set
svm.model = train(output1 ~ ., data = trainset,
method = “svmRadial”,metric = “ROC”,
tuneGrid=tunGrid_svm, trControl = control,
preProc=c(“center”,”scale”))
rpart.model = train(output1 ~ ., data = trainset,
method = “rpart”, metric = “ROC”,
trControl = control, preProc=c(“center”,”scale”))
tunGrid=expand.grid(size=c(9),decay=c(0.2))
#number of hidden neurons (size) and
decay rate optimized separately based on ROC on
training set
nnet.model = train(output1 ~ ., data=trainset,
method = “nnet”, metric=”ROC”,
trace=FALSE, trControl=control, tuneGrid=tunGrid,
preProc=c(“center”,”scale”))
tunegrid=expand.grid(.mtry=c(12)) #mtry which is
number of branches to random forest
optimized based on ROC on training set
rfor.model = train(output1 ~ ., data=trainset,
method = “rf”, metric=”ROC”,
trControl=control,tuneGrid=tunegrid,
preProc=c(“center”,”scale”))
#make predictions based on models
glm.probs = predict(glm.model, testset[,!
names(testset) %in% c(“output1”)], type = “prob”)
svm.probs = predict(svm.model, testset[,!
names(testset) %in% c(“output1”)], type = “prob”)
rpart.probs = predict(rpart.model, testset[,!
names(testset) %in% c(“output1”)], type = “prob”)
nnet.probs=predict(nnet.model, testset[,!
names(testset) %in% c(“output1”)], type = “prob”)
rfor.probs=predict(rfor.model, testset[,!
names(testset) %in% c(“output1”)], type = “prob”)
#make ROC graphs
MARSHALL JOURNAL OF

MEDICINE
™

Expanding Knowledge to Improve Rural Health.

png(www)
glm.ROC = roc(response = testset[, c(“output1”)],
predictor = glm.probs $yes, levels =
levels(testset[, c(“output1”)]))
plot(glm.ROC,add=F, col =” red”,main=k)
svm.ROC = roc(response = testset[, c(“output1”)],
predictor = svm.probs $yes, levels =
levels(testset[, c(“output1”)]))
plot(svm.ROC, add = TRUE, col =”green”)
rpart.ROC = roc(response = testset[, c(“output1”)],
predictor = rpart.probs $yes, levels =
levels(testset[, c(“output1”)]))
plot(rpart.ROC, add = TRUE, col =”blue”)
nnet.ROC=roc(response = testset[, c(“output1”)],
predictor = nnet.probs $yes, levels =
levels(testset[, c(“output1”)]))
plot(nnet.ROC, add = TRUE, col =”orange”)
rfor.ROC=roc(response = testset[, c(“output1”)],
predictor = rfor.probs $yes, levels =
levels(testset[, c(“output1”)]))
plot(rfor.ROC, add = TRUE, col =”purple”)
dev.off() #close ROC graph
sink(vvv) #open text output
#confusion matrices and variable importance lists
glm.pred=predict(glm.
model,testset[,!names(testset)%in% c(“output1”)])
t=table(glm.pred,testset[,c(“output1”)])
tt=confusionMatrix(glm.pred,testset[,c(“output1”)])
print(“glm.model”)
print(tt)
print(glm.ROC)
print(varImp(glm.model))
svm.pred=predict(svm.
model,testset[,!names(testset)%in% c(“output1”)])
t=table(svm.pred,testset[,c(“output1”)])
tt=confusionMatrix(svm.pred,testset[,c(“output1”)])
print(“svm.model”)
print(tt)#
print(svm.ROC)
print(varImp(svm.model))
rpart.pred=predict(rpart.
model,testset[,!names(testset)%in% c(“output1”)])
t= table(rpart.pred,testset[,c(“output1”)])
tt=confusionMatrix(rpart.pred,testset[,c(“output1”)])
print(rpart.ROC)
print(varImp(rpart.model))
nnet.pred=predict(nnet.
model,testset[,!names(testset)%in% c(“output1”)])
t= table(nnet.pred,testset[,c(“output1”)])
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tt=confusionMatrix(nnet.pred,testset[,c(“output1”)])
print(“nnet.model”)
print(tt)
print(nnet.ROC)
print(varImp(nnet.model))
rfor.pred=predict(rfor.
model,testset[,!names(testset)%in% c(“output1”)])
t=table(rfor.pred,testset[,c(“output1”)])
tt=confusionMatrix(rfor.pred,testset[,c(“output1”)])
print(“rfor.model”)
print(tt)
print(rfor.ROC)
print(varImp(rfor.model))
sink() #close text file
}#end loop

MARSHALL JOURNAL OF

MEDICINE
™

Expanding Knowledge to Improve Rural Health.

mds.marshall.edu/mjm
© 2022 Marshall Journal of Medicine

Marshall Journal of Medicine
Volume 4 Issue 4

